F.D.A. Panel Backs Pre-Surgery Drug for Breast Cancer
Thursday, September 12, 2013 - 23:40
in Health & Medicine
Perjeta, a Genentech drug already approved for late-stage breast cancer, could be used in patients before surgery to remove tumors if the F.D.A. approves it.